Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid

Br J Haematol. 2004 Apr;125(1):91-2; author reply 93-4. doi: 10.1111/j.1365-2141.2004.04871.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Insulin-Like Growth Factor I / metabolism
  • Male
  • Osteoporosis / drug therapy*
  • Zoledronic Acid
  • beta-Thalassemia / complications*

Substances

  • Diphosphonates
  • Imidazoles
  • Insulin-Like Growth Factor I
  • Zoledronic Acid